文献速递乳腺US

利用光声乳腺成像对可疑恶性乳腺肿块进行降级分类

Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging.
PubMed 文献 · Radiology · 2018-04-17

这项前瞻性多中心研究纳入209例患者215个超声BI-RADS 4a或4b乳腺肿块,评估光声超声在重新分类中的价值。光声超声将47.9%的4a良性肿块和11.1%的4b良性肿块正确降级至BI-RADS 3或2,假阴性率为4.5%(3/67)。

要点

  • 光声超声可将47.9%(57/119)的BI-RADS 4a良性肿块正确降级至3或2类。
  • BI-RADS 4b良性肿块中11.1%(3/27)被正确降级,比例低于4a。
  • 总假阴性率4.5%(3/67),即少数恶性肿块被不适当降级。

核心结论

  • 光声超声可使BI-RADS 4a良性肿块降级,可能减少阴性活检和短期随访检查,但少数肿块可能被不适当降级。

研究设计与样本

  • 前瞻性多中心研究,209例患者215个乳腺肿块,2015至2016年入组,先以超声评估并赋BI-RADS分类,再以光声超声重新评估并基于五个光声特征评分加权和重新赋概率与分类。

关键影像表现/征象

  • 光声超声利用激光检测可疑乳腺肿块内及周围氧合与脱氧血红蛋白的相对含量。
  • 放射科医师在光声超声评估中评分五个光声特征,并据此重新赋恶性概率和BI-RADS分类。

诊断标准与关键数值

  • BI-RADS 4a良性肿块中47.9%(57/119;95% CI:0.39,0.57)被正确降级至BI-RADS 3或2。
  • BI-RADS 4b良性肿块中11.1%(3/27;95% CI:0.03,0.28)被正确降级至BI-RADS 3或2。
  • 超声BI-RADS 4a的7个恶性肿块中2个被错误降级,BI-RADS 4b的60个恶性肿块中1个被错误降级,总假阴性率4.5%(3/67;95% CI:0.01,0.13)。

临床应用与阅片要点

  • 光声超声重新评估时依据五个光声特征评分的加权和进行降级或升级判断。
  • 降级决策需权衡正确降级良性肿块与错误降级恶性肿块的风险,原文报告总假阴性率为4.5%(3/67)。

局限性

  • 原文指出局限性为少数肿块可能被不适当降级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To assess the ability of optoacoustic (OA) ultrasonography (US) to help correctly downgrade benign masses classified as Breast Imaging Reporting and Data System (BI-RADS) 4a and 4b to BI-RADS 3 or 2. Materials and Methods OA/US technology uses laser light to detect relative amounts of oxygenated and deoxygenated hemoglobin in and around suspicious breast masses. In this prospective, multicenter study, results of 209 patients with 215 breast masses classified as BI-RADS 4a or 4b at US are reported. Patients were enrolled between 2015 and 2016. Masses were first evaluated with US with knowledge of previous clinical information and imaging results, and from this information a US imaging-based probability of malignancy (POM) and BI-RADS category were assigned to each mass. The same masses were then re-evaluated at OA/US. During the OA/US evaluation, radiologists scored five OA/US features, and then reassigned an OA/US-based POM and BI-RADS category for each mass. BI-RADS downgrade and upgrade percentages at OA/US were assessed by using a weighted sum of the five OA feature scores. Results At OA/US, 47.9% (57 of 119; 95% CI: 0.39, 0.57) of benign masses classified as BI-RADS 4a and 11.1% (three of 27; 95% CI: 0.03, 0.28) of masses classified as BI-RADS 4b were correctly downgraded to BI-RADS 3 or 2. Two of seven malignant masses classified as BI-RADS 4a at US were incorrectly downgraded, and one of 60 malignant masses classified as BI-RADS 4b at US was incorrectly downgraded for a total of 4.5% (three of 67; 95% CI: 0.01, 0.13) false-negative findings. Conclusion At OA/US, benign masses classified as BI-RADS 4a could be downgraded in BI-RADS category, which would potentially decrease biopsies negative for cancer and short-interval follow-up examinations, with the limitation that a few masses may be inappropriately downgraded.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Menezes GLG, Pijnappel RM, Meeuwis C, et al. Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging. Radiology. 2018. PMID: 29664342. doi:10.1148/radiol.2018170500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。